Please check your internet connection and try again.
# Walethmade%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520bromide
## Overview
Walethmade%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520bromide is an inorganic bromide salt.
## Primary Indications
* Management of epilepsy (adjunctive therapy).
* Management of insomnia (historical, not a current standard of care due to safety concerns).
## Adult Dosing
* **Epilepsy:** Dosing is highly individualized. Titration is essential. Typical starting doses are low and increased gradually. Maintenance doses can range from 1 gram to 4 grams per day, divided into 2-4 doses. Maximum daily dose is typically not to exceed 6 grams. Specific dosing regimens depend on patient response and tolerability and may require consultation with neurology.
## Pediatric Dosing
* There is no established pediatric dosing for Walethmade%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520bromide for epilepsy in current literature. Use in pediatric populations is not recommended due to lack of safety and efficacy data and significant risks.
## Dose Adjustments
* **Renal Impairment:** Bromide is renally excreted. Dose reduction and careful monitoring are necessary in patients with impaired renal function.
* **Elderly:** May be more susceptible to CNS adverse effects; consider lower starting doses and slower titration.
## Contraindications
* Hypersensitivity to bromides.
* Severe renal impairment.
## Adverse Effects
* **CNS:** Drowsiness, lethargy, confusion, memory impairment, ataxia, headache, delirium, psychosis (bromism).
* **GI:** Nausea, vomiting, anorexia.
* **Dermatologic:** Acneiform rash (bromoderma), urticaria.
* **Other:** Muscle weakness, fatigue.
## Key Drug Interactions
* **CNS Depressants (e.g., alcohol, sedatives, opioids, other antiepileptic drugs):** Additive CNS depression.
* **Diuretics (e.g., loop diuretics, thiazides):** May increase bromide elimination and reduce efficacy.
* **Nephrotoxic agents:** Increased risk of toxicity due to impaired renal bromide excretion.
## Monitoring
* **Serum Bromide Levels:** Essential for guiding therapy and assessing for toxicity. Target levels are typically 100-200 mg/dL, but individual goals may vary. Levels above 200-300 mg/dL are associated with increased risk of bromism.
* **Renal Function:** Monitor BUN and creatinine.
* **Neurological Status:** Assess for signs and symptoms of CNS depression or psychosis.
* **Skin Examination:** Monitor for rash.
## Clinical Pearls
* Bromism is a serious condition resulting from chronic bromide accumulation and can present with a wide range of neuropsychiatric symptoms.
* Long half-life of bromide (about 12 days) means accumulation can occur even with seemingly small daily doses.
* Discontinuation of bromide therapy should be gradual to avoid withdrawal symptoms.
* Due to the narrow therapeutic index and potential for toxicity, Walethmade%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520bromide is generally not a first-line agent for epilepsy.
***
*Disclaimer: This information is intended for healthcare professionals and should not be used as a substitute for clinical judgment. Always consult the most current prescribing information and relevant literature before making treatment decisions.*
